Zoetis ZTS
NYSE ZTS
$73.11 -0.45 (-0.61%)
As of: Sep 9, 2026 · 3:51 PM EDT

Zoetis (ZTS) Short-term Investments (2017 - 2026)

Zoetis' (ZTS) quarterly Short-term Investments came in at $200.0 million in Q2 2026, up 9900.0% quarter-over-quarter from $2.0 million in Q4 2020.

Analysis

Zoetis (ZTS) Short-term Investments (2017 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Short-term Investments for 5 consecutive years, with $200.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Short-term Investments changed N/A year-over-year to $200.0 million in Q2 2026; TTM through Jun 2026 was $200.0 million, a N/A change from a year earlier, with the FY2020 full-year figure at $2.0 million, changed 0.0% from the prior year.
  • Short-term Investments was $200.0 million for Q2 2026 at Zoetis, up from $2.0 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $200.0 million in Q2 2026 and troughed at $200.0 million in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Idexx Laboratories 40.64 Bn 40.44 Bn 779.09 Mn
2 Zoetis 30.58 Bn 28.90 Bn 1.05 Bn
3 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn
4 Phibro Animal Health 1.49 Bn 1.41 Bn 134.40 Mn
5 Immucell 89.92 Mn 81.06 Mn 2.44 Mn
6 Zhengye Biotechnology Holding 74.81 Mn 67.72 Mn -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 200.00 Mn
Dec 31, 2020 2.00 Mn
Sep 30, 2020 3.00 Mn
Mar 31, 2020 1.00 Mn
Dec 31, 2019 2.00 Mn
Sep 30, 2019 12.00 Mn
Jun 30, 2019 25.00 Mn
Mar 31, 2019 65.00 Mn
Dec 31, 2018 99.00 Mn
Sep 30, 2018 105.00 Mn
Jun 30, 2018 5.00 Mn
Mar 31, 2018 6.00 Mn
Dec 31, 2017 6.00 Mn
Oct 1, 2017 7.00 Mn
Jul 2, 2017 7.00 Mn